Clinical trial
Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
NCT04354064
Study timeline
Study start (actual)2019-05-29Date precision: day
Registry last updated2026-02-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Healthy Volunteerunresolved
Prostate Cancerunresolved
Head and Neck Cancerunresolved
Esophageal Cancerunresolved
Genitourinary Cancerunresolved
Sarcomaunresolved
Breast Cancerunresolved
Colon Cancerunresolved
Gastrointestinal Cancerunresolved
Solid Tumor Cancerunresolved
Lung Cancerunresolved
Skin Cancerunresolved
Melanomaunresolved
Interventions
Sponsors & collaborators
Washington University School of Medicinelead sponsor
Roche Sequencing Solutionscollaborator
The Foundation for Barnes-Jewish Hospitalcollaborator
Radiological Society of North Americacollaborator
Skandalariscollaborator
The V Foundation for Cancer Researchcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04354064 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.